Have you read these stories?

A $21-billion slugfest between telecom firms comes down to just $2

New Delhi wants nearly $21 billion in back license fees and spectrum usage charges, including penalties, interest .

Prohibition of drugs

Jan 22, 2020, 11.49 AM IST

SEARCHED FOR:

PROHIBITION OF DRUGS

18% of Indian pharma launches to be delayed in US, says Crisil

The warning letter issued by USFDA to large pharma companies more than doubled in the first 10 months of 2019 compared with the previous year, CRISIL said, adding that close to 180 generic drug launches will be pushed out from their intended launch dates due to it.

Pain for big Indian pharma companies continue warns CRISIL, as FDA woes remains unresolved

Indian drug makers in the last few years have dive...

USFDA in active mode, issues obersvations to 4 drug makers in 3 days!

SMS Pharma today informed exchanges that the United States Food and Dru...

ET Prime Distribution
Load More...
x

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service